The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.

NCT03690778 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Hyperlipidemias

Interventions

DRUG: "Metformin" and "Rosuvastatin" seperately
DRUG: JLP-1310

Sponsor

Jeil Pharmaceutical Co., Ltd.